The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knuehl, C.
Right arrow Articles by Kloetzel, P.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knuehl, C.
Right arrow Articles by Kloetzel, P.-M.
The Journal of Immunology, 2001, 167: 1515-1521.
Copyright © 2001 by The American Association of Immunologists

The Murine Cytomegalovirus pp89 Immunodominant H-2Ld Epitope Is Generated and Translocated into the Endoplasmic Reticulum as an 11-Mer Precursor Peptide1

Christine Knuehl*, Pieter Spee{dagger}, Thomas Ruppert2,*, Ulrike Kuckelkorn*, Peter Henklein*, Jacques Neefjes{dagger} and Peter-M. Kloetzel3,*

* Institute of Biochemistry, Medical Faculty, Charité, Humboldt University, Berlin, Germany; and {dagger} Division of Tumor Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands

The 20S proteasome is involved in the processing of MHC class I-presented Ags. A number of epitopes is known to be generated as precursor peptides requiring trimming either before or after translocation into the endoplasmic reticulum (ER). In this study, we have followed the proteasomal processing and TAP-dependent ER translocation of the immunodominant epitope of the murine CMV immediate early protein pp89. For the first time, we experimentally linked peptide generation by the proteasome system and TAP-dependent ER translocation. Our experiments show that the proteasome generates both an N-terminally extended 11-mer precursor peptide as well as the correct H2-Ld 9-mer epitope, a process that is accelerated in the presence of PA28. Our direct peptide translocation assays, however, demonstrate that only the 11-mer precursor peptide is transported into the ER by TAPs, whereas the epitope itself is not translocated. In consequence, our combined proteasome/TAP assays show that the 11-mer precursor is the immunorelevant peptide product that requires N-terminal trimming in the ER for MHC class I binding.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
K. Textoris-Taube, P. Henklein, S. Pollmann, T. Bergann, H. Weisshoff, U. Seifert, I. Drung, C. Mugge, A. Sijts, P.-M. Kloetzel, et al.
The N-terminal Flanking Region of the TRP2360-368 Melanoma Antigen Determines Proteasome Activator PA28 Requirement for Epitope Liberation
J. Biol. Chem., April 27, 2007; 282(17): 12749 - 12754.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
J. Yan, V. V. Parekh, Y. Mendez-Fernandez, D. Olivares-Villagomez, S. Dragovic, T. Hill, D. C. Roopenian, S. Joyce, and L. Van Kaer
In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules
J. Exp. Med., March 20, 2006; 203(3): 647 - 659.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
D. Bruder, A. K. Nussbaum, D. M. Gakamsky, M. Schirle, S. Stevanovic, H. Singh-Jasuja, A. Darji, T. Chakraborty, H. Schild, I. Pecht, et al.
Multiple synergizing factors contribute to the strength of the CD8+ T cell response against listeriolysin O
Int. Immunol., January 1, 2006; 18(1): 89 - 100.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M.-F. Pahl-Seibert, M. Juelch, J. Podlech, D. Thomas, P. Deegen, M. J. Reddehase, and R. Holtappels
Highly Protective In Vivo Function of Cytomegalovirus IE1 Epitope-Specific Memory CD8 T Cells Purified by T-Cell Receptor-Based Cell Sorting
J. Virol., May 1, 2005; 79(9): 5400 - 5413.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Khan, A. Zimmermann, M. Basler, M. Groettrup, and H. Hengel
A Cytomegalovirus Inhibitor of Gamma Interferon Signaling Controls Immunoproteasome Induction
J. Virol., February 15, 2004; 78(4): 1831 - 1842.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Samino, D. Lopez, S. Guil, P. de Leon, and M. Del Val
An Endogenous HIV Envelope-derived Peptide without the Terminal NH3+ Group Anchor Is Physiologically Presented by Major Histocompatibility Complex Class I Molecules
J. Biol. Chem., January 9, 2004; 279(2): 1151 - 1160.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W. M. Cohen, A. Bianco, F. Connan, L. Camoin, M. Dalod, G. Lauvau, E. Ferries, B. Culmann-Penciolelli, P. M. van Endert, J. P. Briand, et al.
Study of Antigen-Processing Steps Reveals Preferences Explaining Differential Biological Outcomes of Two HLA-A2-Restricted Immunodominant Epitopes from Human Immunodeficiency Virus Type 1
J. Virol., September 11, 2002; 76(20): 10219 - 10225.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Holtappels, D. Thomas, J. Podlech, and M. J. Reddehase
Two Antigenic Peptides from Genes m123 and m164 of Murine Cytomegalovirus Quantitatively Dominate CD8 T-Cell Memory in the H-2d Haplotype
J. Virol., January 1, 2002; 76(1): 151 - 164.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Lopez, Y. Samino, U. H. Koszinowski, and M. Del Val
HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope
J. Immunol., October 15, 2001; 167(8): 4238 - 4244.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.